128 related articles for article (PubMed ID: 15467017)
1. Pathophysiology of coronary heart disease: a brief review.
Chilton RJ
J Am Osteopath Assoc; 2004 Sep; 104(9 Suppl 7):S5-8. PubMed ID: 15467017
[TBL] [Abstract][Full Text] [Related]
2. Reducing the risk of coronary heart disease via lipid reduction.
Spratt KA
J Am Osteopath Assoc; 2004 Sep; 104(9 Suppl 7):S9-13. PubMed ID: 15467018
[TBL] [Abstract][Full Text] [Related]
3. Implications of cardiac risk and low-density lipoprotein cholesterol distributions in the United States for the diagnosis and treatment of dyslipidemia: data from National Health and Nutrition Examination Survey 1999 to 2002.
Keevil JG; Cullen MW; Gangnon R; McBride PE; Stein JH
Circulation; 2007 Mar; 115(11):1363-70. PubMed ID: 17353444
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
5. Retrospective review of sex differences in the management of dyslipidemia in coronary heart disease: an analysis of patient data from a Maryland-based health maintenance organization.
Cooke CE; Hammerash WJ
Clin Ther; 2006 Apr; 28(4):591-9. PubMed ID: 16750470
[TBL] [Abstract][Full Text] [Related]
6. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
Sorensen SV; Frick KD; Wade A; Simko R; Burge R
Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein in 2005. Interview by Peter C. Block.
Ridker PM
J Am Coll Cardiol; 2005 Jul; 46(1):CS2-5. PubMed ID: 16007748
[TBL] [Abstract][Full Text] [Related]
8. Statins and LDL-cholesterol lowering: an overview.
Stroes E
Curr Med Res Opin; 2005; 21 Suppl 6():S9-16. PubMed ID: 16138936
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol, coronary heart disease and stroke: a review of published evidence from observational studies and randomized controlled trials.
Huxley R; Lewington S; Clarke R
Semin Vasc Med; 2002 Aug; 2(3):315-23. PubMed ID: 16222621
[TBL] [Abstract][Full Text] [Related]
10. Coronary heart disease prevention in women: focus on lipids.
Larosa JH; Larosa JC
Minerva Cardioangiol; 2006 Jun; 54(3):311-22. PubMed ID: 16733505
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol and coronary events. The current thinking.
Jones PH
Postgrad Med; 2003 Apr; 113(4 Suppl):5-14. PubMed ID: 19667618
[TBL] [Abstract][Full Text] [Related]
12. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
Daskalopoulou SS; Mikhailidis DP
Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035
[TBL] [Abstract][Full Text] [Related]
13. Management of hyperlipidemia: new LDL-C targets for persons at high-risk for cardiovascular events.
Balbisi EA
Med Sci Monit; 2006 Feb; 12(2):RA34-9. PubMed ID: 16449961
[TBL] [Abstract][Full Text] [Related]
14. New evidence supporting aggressive lipid lowering.
Stein EA
Postgrad Med; 2003 Apr; 113(4 Suppl):31-40. PubMed ID: 19667621
[TBL] [Abstract][Full Text] [Related]
15. Low-density lipoprotein cholesterol reduction: the end is more important than the means.
LaRosa JC
Am J Cardiol; 2007 Jul; 100(2):240-2. PubMed ID: 17631077
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: the alliance study.
Koren MJ; Hunninghake DB;
J Am Coll Cardiol; 2004 Nov; 44(9):1772-9. PubMed ID: 15519006
[TBL] [Abstract][Full Text] [Related]
17. Practicing effective preventive medicine. Pharmacologic interventions in coronary heart disease.
Eisenberg DA
Postgrad Med; 2003 Apr; 113(4 Suppl):24-30. PubMed ID: 19667620
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men.
St-Pierre AC; Cantin B; Dagenais GR; Després JP; Lamarche B
Am J Cardiol; 2006 Apr; 97(7):997-1001. PubMed ID: 16563904
[TBL] [Abstract][Full Text] [Related]
19. The national cholesterol education program adult treatment panel ill guidelines.
Clearfield MB
J Am Osteopath Assoc; 2003 Jan; 103(1 Suppl 1):S1-5. PubMed ID: 12572622
[TBL] [Abstract][Full Text] [Related]
20. Past, present, and future standards for management of dyslipidemia.
LaRosa JC; Gotto AM
Am J Med; 2004 Mar; 116 Suppl 6A():3S-8S. PubMed ID: 15050186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
